FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2040953179> ?p ?o ?g. }

• W2040953179 endingPage "320" @default.
• W2040953179 startingPage "311" @default.
• W2040953179 abstract "In immunocompetent patients, HSV is controlled rapidly by the human host's immune system, and recurrent lesions are small and short lived. When treated with antiviral agents, these patients rarely develop resistance to these drugs. In contrast immunocompromised patients might not be able to control HSV infection. Thus, frequent and severe reactivations are often seen and might lead to fatal herpetic encephalitis or disseminated HSV infection. Treatment in these patients is limited because immunocompromised hosts often develop severe herpes disease refractory to antiviral drug therapy. It is therefore imperative that physicians develop regimens to deal with both receptive and refractory HSV disease. The following treatment protocol (modified from Balfour and colleagues) might serve as a guide until further investigation of new drugs is performed. In all patients standard oral ACV therapy should be initiated at a dose of 200 mg orally, five times a day for the first 3 to 5 days. Prior to treatment, cultures the lesions should be obtained to verify HSV etiology. If the response is poor, the dose of oral ACV should be increased to 800 mg five times a day. If no response seen after 5 to 7 days, it is unlikely that the lesion will respond to intravenous ACV (or chemically and structurally related drugs such as VCV or famciclovir), so an alternative regimen must be assigned. First, repeat cultures for vital, fungal, and bacterial pathogens must be performed. In addition, ACV susceptibility studies should be ordered, if available. If the mucocutaneous lesion is accessible for topical treatment, TFT (as ophthalmic solution) should be applied to the area three to four times a day until the lesion is completely healed. If the lesion is inaccessible or if the response to TFT is poor, therapy with intravenous foscarnet should be given for 10 days or until complete resolution of the lesions. The dosage of foscarnet should be 40 milligrams per kilogram three times per day or 60 milligrams per kilogram twice daily. If foscarnet fails to achieve clinical clearing, consideration should be given to use of intravenous cidofovir (or application of compounded 1% to 3% topical cidofovir ointment). Vidarabine is reserved for situations in which all of these therapies fail. If lesions reoccur in the same location following clearing, the patient should started on high-dose oral ACV (800 mg, five times daily) or intravenous foscarnet (40 mg/kg tid or 60 mg/kg bid) as soon as possible. When lesions occur in a different location, the patient should be treated initially with standard doses of oral ACV (200 mg, five times daily) and the above protocol should be followed should there be clinical failure. In the future, new treatment options for patients with documented HSV resistance will be important in reducing the clinical impact of HSV." @default.
• W2040953179 created "2016-06-24" @default.
• W2040953179 creator A5020149755 @default.
• W2040953179 creator A5054555158 @default.
• W2040953179 date "2003-04-01" @default.
• W2040953179 modified "2023-09-27" @default.
• W2040953179 title "Management of acyclovir-resistant herpes simplex virus" @default.
• W2040953179 cites W1150959 @default.
• W2040953179 cites W1824022572 @default.
• W2040953179 cites W1946935667 @default.
• W2040953179 cites W1964007399 @default.
• W2040953179 cites W1964046951 @default.
• W2040953179 cites W1964359729 @default.
• W2040953179 cites W1965179416 @default.
• W2040953179 cites W1966203536 @default.
• W2040953179 cites W1967027894 @default.
• W2040953179 cites W1968119676 @default.
• W2040953179 cites W1971641536 @default.
• W2040953179 cites W1976152936 @default.
• W2040953179 cites W1978618775 @default.
• W2040953179 cites W1983098285 @default.
• W2040953179 cites W1985270166 @default.
• W2040953179 cites W1985857665 @default.
• W2040953179 cites W1986052834 @default.
• W2040953179 cites W1987386199 @default.
• W2040953179 cites W1989186062 @default.
• W2040953179 cites W1989762644 @default.
• W2040953179 cites W1990570294 @default.
• W2040953179 cites W1995009580 @default.
• W2040953179 cites W1997133348 @default.
• W2040953179 cites W1997521201 @default.
• W2040953179 cites W1998692639 @default.
• W2040953179 cites W1999480417 @default.
• W2040953179 cites W2002339714 @default.
• W2040953179 cites W2006902703 @default.
• W2040953179 cites W2008631953 @default.
• W2040953179 cites W2008890062 @default.
• W2040953179 cites W2008964131 @default.
• W2040953179 cites W2011157541 @default.
• W2040953179 cites W2012325833 @default.
• W2040953179 cites W2016559418 @default.
• W2040953179 cites W2017025205 @default.
• W2040953179 cites W2019409293 @default.
• W2040953179 cites W2021204001 @default.
• W2040953179 cites W2021314445 @default.
• W2040953179 cites W2021690030 @default.
• W2040953179 cites W2021931329 @default.
• W2040953179 cites W2022575978 @default.
• W2040953179 cites W2024773934 @default.
• W2040953179 cites W2025975417 @default.
• W2040953179 cites W2027365708 @default.
• W2040953179 cites W2029281897 @default.
• W2040953179 cites W2033896172 @default.
• W2040953179 cites W2041939667 @default.
• W2040953179 cites W2044086664 @default.
• W2040953179 cites W2047415999 @default.
• W2040953179 cites W2048391354 @default.
• W2040953179 cites W2049265285 @default.
• W2040953179 cites W2049985064 @default.
• W2040953179 cites W2050962071 @default.
• W2040953179 cites W2052460032 @default.
• W2040953179 cites W2052544581 @default.
• W2040953179 cites W2055869272 @default.
• W2040953179 cites W2058627191 @default.
• W2040953179 cites W2059286898 @default.
• W2040953179 cites W2061277962 @default.
• W2040953179 cites W2062026734 @default.
• W2040953179 cites W2063399192 @default.
• W2040953179 cites W2064345637 @default.
• W2040953179 cites W2065017546 @default.
• W2040953179 cites W2065088720 @default.
• W2040953179 cites W2065331362 @default.
• W2040953179 cites W2067118642 @default.
• W2040953179 cites W2069711032 @default.
• W2040953179 cites W2074908890 @default.
• W2040953179 cites W2076110701 @default.
• W2040953179 cites W2076384352 @default.
• W2040953179 cites W2077215436 @default.
• W2040953179 cites W2079568712 @default.
• W2040953179 cites W2084375481 @default.
• W2040953179 cites W2085179561 @default.
• W2040953179 cites W2086050561 @default.
• W2040953179 cites W2086098901 @default.
• W2040953179 cites W2087243502 @default.
• W2040953179 cites W2088152779 @default.
• W2040953179 cites W2089573997 @default.
• W2040953179 cites W2092099664 @default.
• W2040953179 cites W2097636796 @default.
• W2040953179 cites W2100700846 @default.
• W2040953179 cites W2105608350 @default.
• W2040953179 cites W2107460170 @default.
• W2040953179 cites W2113779681 @default.
• W2040953179 cites W2124173580 @default.
• W2040953179 cites W2129479683 @default.
• W2040953179 cites W2130166897 @default.
• W2040953179 cites W2132911514 @default.
• W2040953179 cites W2143590747 @default.
• W2040953179 cites W2150548598 @default.

• next